Beam Therapeutics (BEAM) Share-based Compensation (IS) (2024 - 2026)
Beam Therapeutics (BEAM) recorded Share-based Compensation (IS) of $19.28 million in Q2 2026, down 20.9% from $24.37 million a year earlier but up 1.2% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a TTM basis, Beam Therapeutics' Share-based Compensation (IS) came in at $81.52 million as of Jun 30, 2026, down 26.4% year-over-year; for FY2025, it was $94.24 million, down 21.9% from FY2024.
- Annual Share-based Compensation (IS) has a three-year compound annual growth rate of 3.8% (FY2022 to FY2025).
- Across earlier years, Share-based Compensation (IS) came in at $120.66 million in FY2024 (+22.3%), $98.65 million in FY2023 (+17.0%) and $84.32 million in FY2022.
- Quarterly Share-based Compensation (IS) has ranged from $19.04 million in Q1 2026 to $31.6 million in Q2 2024 over the past five years.
- On a year-over-year basis, Share-based Compensation (IS) has declined for six consecutive quarters, with an average decline of 22.8% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $19.04 million (Q1 2026), $20.45 million (Q4 2025) and $22.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Beam Therapeutics | 2.50 Bn | 2.50 Bn | - | 19.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.28 Mn |
| Mar 31, 2026 | 19.04 Mn |
| Dec 31, 2025 | 20.45 Mn |
| Sep 30, 2025 | 22.75 Mn |
| Jun 30, 2025 | 24.37 Mn |
| Mar 31, 2025 | 26.68 Mn |
| Dec 31, 2024 | 30.22 Mn |
| Sep 30, 2024 | 29.56 Mn |
| Jun 30, 2024 | 31.60 Mn |
| Mar 31, 2024 | 29.28 Mn |
API Access
Beam Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();